Histopathologic differences account for racial disparity in uterine cancer survival

David Smotkin, Nicole S. Nevadunsky, Kimala Harris, Mark H. Einstein, Yiting Yu, Gary L. Goldberg

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: The incidence for uterine cancers has been reported to be higher among white women, whereas mortality is higher among black women. Reasons for the higher mortality among black women are not completely understood. The aim of our study is to examine the relationship between race/ethnicity, histopathologic subtype, and survival in uterine cancer. Methods: We abstracted socio-demographic, treatment, and survival data for all women who were diagnosed with uterine cancer at Montefiore Medical Center from January 1999 through December 2009. Pathology records were reviewed. Results: 984 patients were identified. Racial/ethnic distribution was 382 (39%) white, 308 (31%) black, 232 (24%) Hispanic, and 62 (6.3%) other races, mixed, or unknown. 592 (60%) patients had endometrioid histology. Blacks were much more likely than whites to have non-endometrioid histologies (p < 0.001), including papillary serous, carcinosarcoma, and leiomyosarcoma. Blacks and Hispanics were at least as likely as whites to receive either chemotherapy or radiation therapy. The hazard ratio for death for black versus white patients was 1.94 (p < 0.001) when all histological subtypes were included. The hazard ratio for Hispanics for death was 1.2 (p = 0.32) compared to whites. However, when patients were divided into endometrioid and non-endometrioid histological subtypes, there was no significant difference in survival by race/ethnicity. Conclusion: Black patients with uterine cancer are much more likely to die and are much more likely to have non-endometrioid histologies than white patients. There are no differences in survival among white, black, or Hispanic women with uterine cancer, after control for histological subtype.

Original languageEnglish (US)
Pages (from-to)616-619
Number of pages4
JournalGynecologic Oncology
Volume127
Issue number3
DOIs
StatePublished - Dec 2012

Fingerprint

Uterine Neoplasms
Hispanic Americans
Survival
Histology
Carcinosarcoma
Leiomyosarcoma
Mortality
Radiotherapy
Demography
Pathology
Drug Therapy
Incidence

Keywords

  • Disparity
  • Histology
  • Racial
  • Survival
  • Uterine cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Histopathologic differences account for racial disparity in uterine cancer survival. / Smotkin, David; Nevadunsky, Nicole S.; Harris, Kimala; Einstein, Mark H.; Yu, Yiting; Goldberg, Gary L.

In: Gynecologic Oncology, Vol. 127, No. 3, 12.2012, p. 616-619.

Research output: Contribution to journalArticle

Smotkin, David ; Nevadunsky, Nicole S. ; Harris, Kimala ; Einstein, Mark H. ; Yu, Yiting ; Goldberg, Gary L. / Histopathologic differences account for racial disparity in uterine cancer survival. In: Gynecologic Oncology. 2012 ; Vol. 127, No. 3. pp. 616-619.
@article{0b0b8e600fb04d9b80fc400c6b9a00e0,
title = "Histopathologic differences account for racial disparity in uterine cancer survival",
abstract = "Objective: The incidence for uterine cancers has been reported to be higher among white women, whereas mortality is higher among black women. Reasons for the higher mortality among black women are not completely understood. The aim of our study is to examine the relationship between race/ethnicity, histopathologic subtype, and survival in uterine cancer. Methods: We abstracted socio-demographic, treatment, and survival data for all women who were diagnosed with uterine cancer at Montefiore Medical Center from January 1999 through December 2009. Pathology records were reviewed. Results: 984 patients were identified. Racial/ethnic distribution was 382 (39{\%}) white, 308 (31{\%}) black, 232 (24{\%}) Hispanic, and 62 (6.3{\%}) other races, mixed, or unknown. 592 (60{\%}) patients had endometrioid histology. Blacks were much more likely than whites to have non-endometrioid histologies (p < 0.001), including papillary serous, carcinosarcoma, and leiomyosarcoma. Blacks and Hispanics were at least as likely as whites to receive either chemotherapy or radiation therapy. The hazard ratio for death for black versus white patients was 1.94 (p < 0.001) when all histological subtypes were included. The hazard ratio for Hispanics for death was 1.2 (p = 0.32) compared to whites. However, when patients were divided into endometrioid and non-endometrioid histological subtypes, there was no significant difference in survival by race/ethnicity. Conclusion: Black patients with uterine cancer are much more likely to die and are much more likely to have non-endometrioid histologies than white patients. There are no differences in survival among white, black, or Hispanic women with uterine cancer, after control for histological subtype.",
keywords = "Disparity, Histology, Racial, Survival, Uterine cancer",
author = "David Smotkin and Nevadunsky, {Nicole S.} and Kimala Harris and Einstein, {Mark H.} and Yiting Yu and Goldberg, {Gary L.}",
year = "2012",
month = "12",
doi = "10.1016/j.ygyno.2012.08.025",
language = "English (US)",
volume = "127",
pages = "616--619",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Histopathologic differences account for racial disparity in uterine cancer survival

AU - Smotkin, David

AU - Nevadunsky, Nicole S.

AU - Harris, Kimala

AU - Einstein, Mark H.

AU - Yu, Yiting

AU - Goldberg, Gary L.

PY - 2012/12

Y1 - 2012/12

N2 - Objective: The incidence for uterine cancers has been reported to be higher among white women, whereas mortality is higher among black women. Reasons for the higher mortality among black women are not completely understood. The aim of our study is to examine the relationship between race/ethnicity, histopathologic subtype, and survival in uterine cancer. Methods: We abstracted socio-demographic, treatment, and survival data for all women who were diagnosed with uterine cancer at Montefiore Medical Center from January 1999 through December 2009. Pathology records were reviewed. Results: 984 patients were identified. Racial/ethnic distribution was 382 (39%) white, 308 (31%) black, 232 (24%) Hispanic, and 62 (6.3%) other races, mixed, or unknown. 592 (60%) patients had endometrioid histology. Blacks were much more likely than whites to have non-endometrioid histologies (p < 0.001), including papillary serous, carcinosarcoma, and leiomyosarcoma. Blacks and Hispanics were at least as likely as whites to receive either chemotherapy or radiation therapy. The hazard ratio for death for black versus white patients was 1.94 (p < 0.001) when all histological subtypes were included. The hazard ratio for Hispanics for death was 1.2 (p = 0.32) compared to whites. However, when patients were divided into endometrioid and non-endometrioid histological subtypes, there was no significant difference in survival by race/ethnicity. Conclusion: Black patients with uterine cancer are much more likely to die and are much more likely to have non-endometrioid histologies than white patients. There are no differences in survival among white, black, or Hispanic women with uterine cancer, after control for histological subtype.

AB - Objective: The incidence for uterine cancers has been reported to be higher among white women, whereas mortality is higher among black women. Reasons for the higher mortality among black women are not completely understood. The aim of our study is to examine the relationship between race/ethnicity, histopathologic subtype, and survival in uterine cancer. Methods: We abstracted socio-demographic, treatment, and survival data for all women who were diagnosed with uterine cancer at Montefiore Medical Center from January 1999 through December 2009. Pathology records were reviewed. Results: 984 patients were identified. Racial/ethnic distribution was 382 (39%) white, 308 (31%) black, 232 (24%) Hispanic, and 62 (6.3%) other races, mixed, or unknown. 592 (60%) patients had endometrioid histology. Blacks were much more likely than whites to have non-endometrioid histologies (p < 0.001), including papillary serous, carcinosarcoma, and leiomyosarcoma. Blacks and Hispanics were at least as likely as whites to receive either chemotherapy or radiation therapy. The hazard ratio for death for black versus white patients was 1.94 (p < 0.001) when all histological subtypes were included. The hazard ratio for Hispanics for death was 1.2 (p = 0.32) compared to whites. However, when patients were divided into endometrioid and non-endometrioid histological subtypes, there was no significant difference in survival by race/ethnicity. Conclusion: Black patients with uterine cancer are much more likely to die and are much more likely to have non-endometrioid histologies than white patients. There are no differences in survival among white, black, or Hispanic women with uterine cancer, after control for histological subtype.

KW - Disparity

KW - Histology

KW - Racial

KW - Survival

KW - Uterine cancer

UR - http://www.scopus.com/inward/record.url?scp=84868600198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868600198&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2012.08.025

DO - 10.1016/j.ygyno.2012.08.025

M3 - Article

C2 - 22940487

AN - SCOPUS:84868600198

VL - 127

SP - 616

EP - 619

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -